Avinger’s Next Generation Pantheris Featured in Live Case Transmission at Leipzig Interventional Course 2018

GlobeNewswire, Inc. Feb 2 2018

Avinger, Inc. (NASDAQ: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), announced that its next generation Pantheris® Lumivascular atherectomy system was featured in a live case transmission at Leipzig Interventional Course (LINC) 2018 held from January 30th through February 2nd at the Trade Fair Leipzig, in Leipzig, Germany. LINC is a leading global forum for new methods in the field of vascular medicine that brings together medical professionals from around the world who perform endovascular interventions. Yesterday Drs. Arne Schwindt and Stefan Stahlhoff, vascular surgeons from St. Franziskus Hospital in Münster, Germany, used the next ...

Read Full Article

Bookmark or Share this article

Login to comment.

Avinger Announces Preliminary Analysis of Results from SCAN Clinical Study also written by Avinger, Inc.
Avinger Announces Commercial Launch in Australia also written by Avinger, Inc.
Lantis Files 15(c) 2-11 With Finra to Obtain Listing On OTC Bulletin Board also published in GlobeNewswire, Inc.
Avinger Announces Presentations by Key Opinion Leaders at AMP 2019 Clinical Conference also written by Avinger, Inc.
Avinger Announces Successful Treatment of 500th Patient with Next-Generation Pantheris Device also written by Avinger, Inc.
Avinger Announces Commercial Launch and First Patients Treated in Hong Kong also written by Avinger, Inc.
Avinger Announces Pantheris SV Limited Launch and Successful Treatment of First Patients in the United States also written by Avinger, Inc.
Lantis Laser CEO to Appear On AOL Finance Small Cap Show Produced by Agoracom also published in GlobeNewswire, Inc.
Lantis Announces President's Investor Update On Strategic Achievements also published in GlobeNewswire, Inc.
Avinger Announces Successful Treatment of 1,000th Patient with Next-Generation Pantheris Device also written by Avinger, Inc.